JD Supra just released its Life Sciences Report for Winter and Spring 2019. The report confirms just how robust the life science investment has been in 2018. Biopharma, Device and Dx/Tool investment grew by more than 50% in 2018 compared to 2017.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,